Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (885)	11/11/1998 11:35:00 AM
From: Joe Copia	Read Replies (1) \| Respond to of 1286

NBMXD nearing a buy-op here. Presently .938 x 1.125 ...... Hearing rumors of news this week about one of the major shareholders, Dr Kidar (sp?), making a strong statement in press release concerning National Boston and its future. We Shall See. Patience will win, imo. Joe PTG&LI !!!

To: Joe Copia who wrote (885)	11/11/1998 12:16:00 PM
From: jhild	Read Replies (1) \| Respond to of 1286

Joe, I am unsure why you find great significance that the product was tested in an FDA certified lab. This does not in any way confer FDA approval on the product. Indeed searching the agency sites indicates that SafeShield has not received any approvals from the FDA or the EPA. It appears to me that as a disinfectant, even though it is used on the hands, it's environmental impact will need to be assessed as it will be coming in contact with foods and there will likely be some transfer to food products. Additionally, it appears to my reading of things that if it is to be marketed as a treatment for any latex allergies, then there will need to be clinical trials to establish its efficacy. I am at a loss to understand why the lab being FDA certified was even mentioned in the release, unless it was to hype and create some illusion that Safeshield itself was FDA approved.